Literature DB >> 10352311

Intracellular expression and release of Fc epsilon RI alpha by human eosinophils.

M C Seminario1, S S Saini, D W MacGlashan, B S Bochner.   

Abstract

Although Fc epsilon R have been detected on human eosinophils, levels varied from moderate to extremely low or undetectable depending on the donor and methods used. We have attempted to resolve the conflicting data by measuring levels of IgE, Fc epsilon RI, and Fc epsilon RII in or on human eosinophils from a variety of donors (n = 26) and late-phase bronchoalveolar lavage fluids (n = 5). Our results demonstrated little or no cell surface IgE or IgE receptors as analyzed by immunofluorescence and flow cytometry. Culture of eosinophils for up to 11 days in the presence or absence of IgE and/or IL-4 (conditions that enhance Fc epsilon R on other cells) failed to induce any detectable surface Fc epsilon R. However, immunoprecipitation and Western blot analysis of eosinophil lysates using mAb specific for Fc epsilon RI alpha showed a distinct band of approximately 50 kDa, similar to that found in basophils. Western blotting also showed the presence of FcR gamma-chain, but no Fc epsilon RI beta. Surface biotinylation followed by immunoprecipitation again failed to detect surface Fc epsilon RI alpha, although surface FcR gamma was easily detected. Since we were able to detect intracellular Fc epsilon RI alpha, we examined its release from eosinophils. Immunoprecipitation and Western blotting demonstrated the release of Fc epsilon RI alpha into the supernatant of cultured eosinophils, peaking at approximately 48 h. We conclude that eosinophils possess a sizable intracellular pool of Fc epsilon RI alpha that is available for release, with undetectable surface levels in a variety of subjects, including those with eosinophilia and elevated serum IgE. The biological relevance of this soluble form of Fc epsilon RI alpha remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352311

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 2.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 3.  IgE and FcepsilonRI regulation.

Authors:  Donald MacGlashan
Journal:  Clin Rev Allergy Immunol       Date:  2005-08       Impact factor: 8.667

Review 4.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

5.  Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors.

Authors:  Natalija Novak; Carmen Tepel; Susanne Koch; Klaudia Brix; Thomas Bieber; Stefan Kraft
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

6.  Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.

Authors:  Emma Comas-Casellas; Águeda Martínez-Barriocanal; Francesc Miró; Aroa Ejarque-Ortiz; Simo Schwartz; Margarita Martín; Joan Sayós
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

7.  Splenic hypereosinophilia in anaphylaxis-related death: different assessments depending on different types of allergens?

Authors:  Luca Reggiani Bonetti; Livia Maccio; Nicoletta Trani; Erjon Radheshi; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2014-05-01       Impact factor: 2.686

Review 8.  Allergic Inflammation in Aspergillus fumigatus-Induced Fungal Asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

9.  The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells.

Authors:  Eva Untersmayr; Giovanna Bises; Philipp Starkl; Charles L Bevins; Otto Scheiner; George Boltz-Nitulescu; Fritz Wrba; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

10.  Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue.

Authors:  Joke Patou; Gabriele Holtappels; Karen Affleck; Philippe Gevaert; Claudina Perez-Novo; Paul Van Cauwenberge; Claus Bachert
Journal:  J Inflamm (Lond)       Date:  2009-04-20       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.